Literature DB >> 29958634

Radiation therapy in renal cell carcinoma.

Francesca De Felice1, Vincenzo Tombolini2.   

Abstract

Renal cell carcinoma (RCC) is classically regarded as extremely resistant to classical fractionated radiation therapy (RT). Nowadays, there is convincing data supporting RCC radiosensitivity to high fraction doses, which may represent an ideal issue for new treatment strategies in primary and oligometastatic RCC disease. This review discusses the role of RT in RCC and its potential therapeutic scenario focusing on the most interesting clinical trials.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ceramide; Oligometastasis; Radioresistance; Radiosensitivity; Radiosurgery; Radiotherapy; Renal cell carcinoma; Stereotactic; kidney

Mesh：

Year:  2018        PMID： 29958634     DOI： 10.1016/j.critrevonc.2018.06.002

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


  8 in total

1.  Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery.

Authors:  U Harmenberg; M Lindskog; G Sinclair; M Stenman; H Benmakhlouf; P Wersäll; P Johnstone; M A Hatiboglu; J Mayer-da-Silva
Journal:  Acta Neurochir (Wien)       Date:  2020-09-09       Impact factor: 2.216

2.  Black Phosphorus Quantum Dots Enhance the Radiosensitivity of Human Renal Cell Carcinoma Cells through Inhibition of DNA-PKcs Kinase.

Authors:  Yue Lang; Xin Tian; Hai-Yue Dong; Xiang-Xiang Zhang; Lan Yu; Ming Li; Meng-Meng Gu; Dexuan Gao; Zeng-Fu Shang
Journal:  Cells       Date:  2022-05-16       Impact factor: 7.666

3.  LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis.

Authors:  Yufeng Jiang; Wei Li; Yang Yan; Xudong Yao; Wenyu Gu; Haimin Zhang
Journal:  Cancer Cell Int       Date:  2020-06-24       Impact factor: 5.722

4.  ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/β-Catenin Signaling Pathway and Predicts Good Prognosis.

Authors:  Yu-Jian Zhang; Lin Zhang; Fei Feng; Qi-Feng Cao
Journal:  Dis Markers       Date:  2021-08-24       Impact factor: 3.434

5.  CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop.

Authors:  Lin-Jing Gong; Xin-Yuan Wang; Xu-Dong Yao; Xu Wu; Wen-Yu Gu
Journal:  Cell Death Dis       Date:  2021-11-13       Impact factor: 8.469

6.  LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.

Authors:  Xiaoguang Zhou; Bowen Zeng; Yansheng Li; Haozhou Wang; Xiaodong Zhang
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

7.  Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a.

Authors:  Yang Liu; Weiwei Cui; Ruihong Zhang; Sujuan Zhi; Lanlan Liu; Xuyue Liu; Xiaoning Feng; Yanru Chen; Xiaoli Zhang; Jing Hao
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

8.  Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis.

Authors:  Qiwei Yang; Weiwei Chu; Wei Yang; Yanqiong Cheng; Chuanmin Chu; Xiuwu Pan; Jianqing Ye; Jianwei Cao; Sishun Gan; Xingang Cui
Journal:  Front Genet       Date:  2020-10-15       Impact factor: 4.599
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.